Acting Federal Trade Commission (FTC) Chairman Maureen K. Ohlhausen announced September 7 that she has selected Ian R. Conner, a partner in the Antitrust & Competition group at the law firm of Kirkland & Ellis LLP, to be an Acting Deputy Director of the FTC’s Bureau of Competition, effective September 18, 2017.
“Ian’s broad experience in antitrust litigation, particularly in the healthcare and energy industries, will be indispensable as the FTC continues to promote growth, innovation and free-market principles by maintaining a vibrant, competitive US economy,” Acting Chairman Ohlhausen said.
In private practice, Conner represented clients before the FTC, the US Department of Justice and various state attorneys general. Prior to entering private practice, Conner was a trial attorney in the Transportation, Energy and Agriculture Section of the US Department of Justice, Antitrust Division, which he joined through the Attorney General’s Honors Program. He also served as a Special Assistant US Attorney in the Eastern District of Virginia.
Mr. Conner received his law degree from William & Mary Law School. He served as an adjunct professor from 2008 to 2010 at William & Mary, teaching a course on antitrust and merger review.
Full Content: Law 360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas